Psychologist and Excellence in Mind member Giselle Bahr has started a newsletter on Substack collating important research about ADHD. Her aim is to impart accurate information to readers so that their conversations about ADHD are richer and more careful.
A resource which inspires and empowers everyone to meaningfully connect with the people around them and start a conversation with those in their world who may be struggling with life
CEP communicates evidence about the potentially harmful effects of psychiatric drugs to the people and institutions in the United Kingdom that can make a difference.
TranspariMED collaborates with other nonprofits to end evidence distortion in medicine.
Based in Toronto, Canada, RxISK was set up by doctors to educate and empower patients to have better conversations about their medications with their doctors and to collect data on the unintended consequences of prescription medications.
The Commission is the kaitiaki of Aotearoa’s mental health and wellbeing — “the eyes and ears of people in Aotearoa”. It amplifies voices from communities, bringing focus to areas where meaningful, long-term transformation about wellbeing can take place.
On behalf of scientists, clinicians, patients and the broader public, the CRIT program promotes transparency and access to key medical product data, including individual participant-level data (IPD) from clinical trials, meta-data associated with clinical trials, and summary results derived from the trials.
The document and webinar below are useful resources to engage with when considering or planning for safe tapering of antidepressant medication